![Kenneth Hallock](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 6 M $ in data 31/08/2026
Kenneth Hallock is currently an Independent Director at Greenwich LifeSciences, Inc., a position held since 2019.
Mr. Hallock completed undergraduate studies at Princeton University and earned an MBA from Harvard Business School.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 26/05/2026 | 397.333 ( 2,71% ) | 6 M $ | 31/08/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| GREENWICH LIFESCIENCES, INC. | Direttore/Membro del Consiglio | 01/09/2019 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 3 |
|---|---|
Princeton University
 Princeton University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Greenwich LifeSciences, Inc.
 Greenwich LifeSciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops immunotherapy to prevent breast cancer recurrences | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
